LON:VSN - Verseon Stock Price, News, & Analysis

Today's Range N/A
50-Day Range
84
MA: GBX 84
84
52-Week Range N/A
VolumeN/A
Average Volume560 shs
Market Capitalization£127.41 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Verseon Corporation, a pharmaceutical company, designs and develops novel therapeutics for various diseases in the United States. The company is involved in developing oral anticoagulants for various cardiovascular indications with novel pharmacology; kallikrein inhibitors for the treatment of diabetic macular edema and hereditary angioedema; and novel angiogenesis inhibitors for the treatment of solid tumors. Verseon Corporation was founded in 2002 and is headquartered in Fremont, California.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-510-2259000

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book ValueGBX 21 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap£127.41 million
Next Earnings DateN/A
OptionableNot Optionable

Receive VSN News and Ratings via Email

Sign-up to receive the latest news and ratings for VSN and its competitors with MarketBeat's FREE daily newsletter.

Verseon (LON:VSN) Frequently Asked Questions

What is Verseon's stock symbol?

Verseon trades on the London Stock Exchange (LON) under the ticker symbol "VSN."

Has Verseon been receiving favorable news coverage?

Press coverage about VSN stock has been trending somewhat negative recently, according to InfoTrie Sentiment. The research group ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Verseon earned a news impact score of -1.1 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 6.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the stock's share price in the near future. View News Stories for Verseon.

Who are some of Verseon's key competitors?

Who are Verseon's key executives?

Verseon's management team includes the folowing people:
  • Mr. Adityo Prakash, CEO & Exec. Director
  • Ms. Eniko Fodor, Founder, CFO, COO, Company Sec. & Exec. Director (Age 51)

How do I buy shares of Verseon?

Shares of VSN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How big of a company is Verseon?

Verseon has a market capitalization of £0.00. View Additional Information About Verseon.

What is Verseon's official website?

The official website for Verseon is http://www.verseon.com/.

How can I contact Verseon?

Verseon's mailing address is 48820 Kato Rd Ste 100B, FREMONT, CA 94538-7323, United States. The company can be reached via phone at +1-510-2259000.


MarketBeat Community Rating for Verseon (LON VSN)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  98 (Vote Outperform)
Underperform Votes:  104 (Vote Underperform)
Total Votes:  202
MarketBeat's community ratings are surveys of what our community members think about Verseon and other stocks. Vote "Outperform" if you believe VSN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VSN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel